Fundz

Olix Announces Completion Of Usd 45 Million Capital Raise For R&D And Financial Structure Improvement

PRIVATEMay 25, 2022

Amount Raised

$45 Million

Round Type

Funding Round

South KoreaBiotechnologyProfessional ServicesHealth CareScience And Engineering

Description

OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced that the Company has successfully completed a capital raise to support the Company’s R&D activities and improve its financial structure.

Quick answer

OliX Pharmaceuticals raised $45 Million in a Funding Round round, dated May 25, 2022. OliX Pharmaceuticals is based in South Korea.

How much did OliX Pharmaceuticals raise?
OliX Pharmaceuticals raised $45 Million in a Funding Round round on May 25, 2022.
What does OliX Pharmaceuticals do?
OliX Pharmaceuticals is a clinical-stage pharmaceutical company developing therapeutics against a variety of disorders by down-regulating the expression of disease-causing genes based on its own proprietary RNAi..
Where is OliX Pharmaceuticals based and how big is it?
OliX Pharmaceuticals is based in South Korea.
Who are the decision-makers at OliX Pharmaceuticals?
Fundz holds 1 contact at OliX Pharmaceuticals, including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Professional Services and Science And Engineering around the same time

Companies in the same sectors as OliX Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • Advanced NanoTherapies raised $7.2M (Series A) on June 28, 2022.
  • PineTree Therapeutics raised $24M (Series A) on June 7, 2022.
  • Upstream Bio raised $200M (Series A) on June 2, 2022.
  • SentinelOne, Inc. raised $8M (Funding Round) on May 30, 2022.
  • 22nd Century raised $58M on May 25, 2022.
  • Vyriad raised $30M (Series B) on May 17, 2022.

Who to call at OliX Pharmaceuticals, and when

A new round usually means OliX Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day OliX Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OliX Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at OliX Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

OliX Pharmaceuticals

Location

South Korea

About

OliX Pharmaceuticals is a clinical-stage pharmaceutical company developing therapeutics against a variety of disorders by down-regulating the expression of disease-causing genes based on its own proprietary RNAi technology. The Company’s core RNAi platform, asymmetric siRNA (asiRNA), is a unique gene silencing technology based on RNA interference (RNAi), which is considered the most efficient gene silencing technology. Utilizing this proprietary asiRNA technology, OliX has developed cell penetrating asiRNA (cp-asiRNA), a therapeutic RNAi platform to effectively target diseases locally, such as hypertrophic scarring, dry and wet age-related macular degeneration (AMD), subretinal fibrosis, and neuropathic pain. OliX has also developed another therapeutic RNAi platform, GalNAc-asiRNA, to target a variety of liver diseases. Learn more: https://www.olixpharma.com/eng

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment OliX Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsHongsuk P., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for OliX Pharmaceuticals's next move

See what Strategic adds

OliX Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.